Antiretroviral Therapy Among HIV-Infected Pregnant Women on Their Offspring
نویسندگان
1 دانشگاه شهید بهشتی
2
3 دانشگاه گیلان
4 دانشگاه شیراز
doi
10.22059/jsciences.2025.364675.1007825چکیده
The risk of mother-to-child transmission (MTCT) of human immunodeficiency virus (HIV) infection is approximately 30%. However, antiretroviral drugs can reduce MTCT to less than 2%. This study was designed to determine the effect of antiretroviral therapy among HIV-infected women and its maternal and neonatal outcomes in Iran. The study is a retrospective analysis of mother-infant data from Shiraz, Southern Iran, between 2006 and 2012. HIV-infected pregnant women were divided into two groups of intervention (receiving treatment or chemoprophylaxis) and control (not receiving any treatment). Maternal and neonatal information were extracted and recorded. The data were entered into SPSS software and were analyzed. The mother-to-child transmission was 2.9% in the intervention group compared to 15.8% in the control group (OR=0.01, 95% CI: 0.002-0.125, p<0.0001). The infant HIV infection rate was significantly higher in male infants (OR=2.76, CI 95% 2.213-3.327), NVD delivery (OR=3.78, CI 95% 3.140-4.409), and breastfeeding (OR=26, CI 95% 7.87-85.90). Treatment intervention significantly reduces the HIV transmission from infected mothers to their infants. However, the rate of vertical transmission in Iran remains higher than those reported in developed countries despite treatment interventions, and additional preventive measures appear necessary.